Abstract
The 5-HT7 receptors (5-HT7Rs) are the most recent classified members of the serotonin family. Characterized in 1993, they belong to the G protein-coupled receptor family. Since their discovery, they have been the subject of intense research due to their widespread distribution in the brain, suggestive of multiple central roles. The focus of this review is to discuss the literature concerning recent advances on 5-HT7Rs and their ligands.
Keywords: Serotonin, serotonin receptor subtypes, 5-HT7Rs, 5-HT7 ligands, G protein-coupled receptors, agonists, antagonists
Mini-Reviews in Medicinal Chemistry
Title: 5-HT7 Receptor Ligands: Recent Developments and Potential Therapeutic Applications
Volume: 7 Issue: 9
Author(s): Valeria Pittala, Loredana Salerno, Maria Modica, Maria Angela Siracusa and Giuseppe Romeo
Affiliation:
Keywords: Serotonin, serotonin receptor subtypes, 5-HT7Rs, 5-HT7 ligands, G protein-coupled receptors, agonists, antagonists
Abstract: The 5-HT7 receptors (5-HT7Rs) are the most recent classified members of the serotonin family. Characterized in 1993, they belong to the G protein-coupled receptor family. Since their discovery, they have been the subject of intense research due to their widespread distribution in the brain, suggestive of multiple central roles. The focus of this review is to discuss the literature concerning recent advances on 5-HT7Rs and their ligands.
Export Options
About this article
Cite this article as:
Pittala Valeria, Salerno Loredana, Modica Maria, Siracusa Angela Maria and Romeo Giuseppe, 5-HT7 Receptor Ligands: Recent Developments and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry 2007; 7 (9) . https://dx.doi.org/10.2174/138955707781662663
DOI https://dx.doi.org/10.2174/138955707781662663 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Focus on Microfluidics and Nanotechnology Approaches for the Ultra Sensitive Detection of MicroRNA
MicroRNA Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Current Neuropharmacology Combating Diseases with Computational Strategies Used for Drug Design and Discovery
Current Topics in Medicinal Chemistry Recent Advances in Epilepsy
Current Neuropharmacology Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis
CNS & Neurological Disorders - Drug Targets A New Class of Anticonvulsants Possessing 6 Hz Psychomotor Seizure Test Activity: 2-(1H-Benzotriazol-1-yl)-N'-[Substituted] Acetohydrazides
Medicinal Chemistry Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies
Current Neuropharmacology Functional Neuroimaging in Memory and Memory Disturbances
Current Medical Imaging Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Current Neuropharmacology Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management
Current Neuropharmacology Cannabinoids
Current Drug Targets - CNS & Neurological Disorders Drug Repurposing Approaches: Existing Leads for Novel Threats and Drug Targets
Current Protein & Peptide Science The Role of <i>Eif2s3y</i> in Mouse Spermatogenesis and ESC
Current Stem Cell Research & Therapy Neurogenic Drugs and Compounds
Recent Patents on CNS Drug Discovery (Discontinued) Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy
Current Neuropharmacology Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
Current Neuropharmacology Preface:
Current Topics in Medicinal Chemistry Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets Editorial (Thematic Issue: Global Trends for Nanotechnological Approaches in Various Health Issues - Part 1)
Current Drug Metabolism